Inhalation Sciences: Entering the Indian market - Redeye

Redeye endorses ISAB's collaboration with a leading Indian pharmaceutical company, recognizing it as a significant stride into the Indian market and expanding ISAB’s geographic footprint in the Asian market. This partnership, driven by ISAB's DissolvIt module, represents a strategic move to improve research precision in drug development within India's growing pharmaceutical sector. In light of this collaboration, we reiterate our base case.

Länk till analysen i sin helhet: https://www.redeye.se/research/945348/inhalation-sciences-entering-the-indian-market?utm_source=finwire&utm_medium=RSS